Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02635074 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped safety

Conditions

Recurrent Adult Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Ibrutinib
DRUG: Idarubicin

Sponsor

Steven E. Coutre

Collaborators

[object Object]